HYDERABAD, India, Dec. 8, 2025 /PRNewswire/ — According to Mordor Intelligence, the global exosomes market is valued at USD 0.71 billion in 2025 and is projected to surpass USD 2.21 billion by 2030, at a 25.5% CAGR during 2025-2030. The market is witnessing strong momentum due to rapid advancements in exosome isolation, characterization, and engineering technologies, which are transforming their role in precision medicine, oncology, regenerative therapies, and liquid biopsy innovations.

The expanding volume of cancer research, increased adoption of liquid biopsy techniques, and rising interest in cell-free therapeutic delivery systems are further accelerating market adoption across clinical and research ecosystems.

Emerging Market Trends

Rise in Exosome-Based Diagnostics

The global shift toward minimally invasive diagnostic tools has significantly boosted the development of exosome-powered assays. These vesicles are increasingly being used to detect biomarkers associated with oncology, neurodegenerative diseases, and metabolic disorders. Diagnostic applications lead current market adoption, supported by their ability to provide high-fidelity molecular insights from blood and other biofluids.

Growing Focus on Exosome Therapeutics

Therapeutic applications are gaining strong traction as researchers and biotech innovators engineer exosomes for targeted drug delivery, gene modulation, and regenerative therapies. Advancements in exosome engineering and scalable GMP-grade production are accelerating clinical-pipeline activity, positioning exosomes as a transformative modality in precision medicine.

Regional Market Insights

North America remains the largest contributor to the global exosomes market, driven by substantial R&D investments, expanding clinical trials, and strong collaborations between biotechnology companies and academic research centers. The region benefits from supportive regulatory pathways and high adoption of advanced biomedical technologies.

Asia-Pacific is projected to record the fastest growth, supported by expanding biotechnology infrastructure, increasing healthcare investments, and government initiatives promoting translational research. Countries such as China, Japan, and South Korea are emerging as high-potential hubs for exosome-based research and manufacturing.

Market Segment Breakdown

By Product Type

Kits & Reagents
Instruments
Services & Software

By Workflow

Isolation Methods
- Ultracentrifugation
- Immuno-affinity Capture
- Polymer-based Precipitation
- Microfluidic Isolation
Downstream Analysis
- Nano-flow Cytometry
- Electron Microscopy
- Mass Spectrometry

By Biomolecule Type

Non-coding RNA (miRNA, lncRNA)
Proteins & Peptides
Lipids
mRNA
DNA Fragments

By Application

Diagnostics
- Cancer
- Neuro-degenerative Diseases
- Infectious Diseases
Therapeutics
- Oncology
- Regenerative Medicine
- Drug Delivery Platforms

By End User

Pharmaceutical & Biotechnology Companies
Academic & Research Institutes
Hospitals & Clinics
Diagnostic Centers

By Geography

North America
Europe
Asia-Pacific
Middle East & Africa
South America

For a full breakdown of market size, segmentation data, and competitive intelligence, access the details of the Mordor Intelligence report: https://www.mordorintelligence.com/industry-reports/exosomes-market?utm_source=prnewswire

Strategic Competitive Environment

The exosomes market is moderately fragmented, with global and emerging players focusing on innovations in exosome isolation technologies, large-scale manufacturing, and therapeutic engineering. Companies are increasingly forming partnerships to advance clinical research, optimize bioinformatics workflows, and develop platform technologies for diagnostics and drug delivery. Strategic collaborations, licensing agreements, and targeted acquisitions continue to shape the competitive landscape as organizations seek to strengthen technological capabilities and broaden application portfolios.

Key Companies Include:

Thermo Fisher Scientific Inc.
Danaher Corp. (Beckman Coulter)
Qiagen N.V.
Lonza Group Ltd
Fujifilm Holdings Corp.

Check out related reports published by Mordor Intelligence:

Epigenetics Market: The epigenetics market is segmented by product (instruments, reagents & kits), application (oncology, neurology & CNS disorders, metabolic diseases, autoimmune diseases), technology (dna methylation analysis, histone modification-acetylation, methylation), and geography (North America, Europe, Asia Pacific).

Thermo Fisher Scientific, Agilent Technologies, Roche, PerkinElmer and QIAGEN are the major companies operating in this market.

Read more about companies active in Epigenetics: https://www.mordorintelligence.com/industry-reports/epigenetics-market/companies?utm_source=prnewswire

In Situ Hybridization Market: The in situ hybridization market is segmented by product (analytical instruments, probes kits & reagents), technique (fluorescence ISH), application (cancer diagnostics & research, infectious diseases), end user (diagnostic laboratories), and geography (North America, Europe, Asia-Pacific, Middle East & Africa, South America).

Roche, Genemed Biotechnologies, Agilent Technologies, Biocare Medical and Thermo Fisher Scientific are the major companies operating in this market.

Read more about companies active in In Situ Hybridization: https://www.mordorintelligence.com/industry-reports/in-situ-hybridization-market/companies?utm_source=prnewswire

Consumer Genomics Market: The consumer genomics market is segmented by application (genetic relatedness, diagnostics), technology (microarray genotyping, SNP genotyping), sample type (saliva, buccal swab), distribution channel (direct-to-consumer, physician-mediated & clinics), and geography (North America, Europe, Asia-Pacific, and More).

23andMe, Ancestry, Positive Bioscience, Futura Genetics and Helix OpCo are the major companies operating in this market.

Read more about companies active in Consumer Genomics:

https://www.mordorintelligence.com/industry-reports/consumer-genomics-market–growth-trends-and-forecast/companies?utm_source=prnewswire

About Mordor Intelligence: 
 
Mordor Intelligence is a trusted partner for businesses seeking comprehensive and actionable market intelligence. Our global reach, expert team, and tailored solutions empower organizations and individuals to make informed decisions, navigate complex markets, and achieve their strategic goals. 
 
With a team of over 550 domain experts and on-ground specialists spanning 150+ countries, Mordor Intelligence possesses a unique understanding of the global business landscape. This expertise translates into comprehensive syndicated and custom research reports covering a wide spectrum of industries, including aerospace & defense, agriculture, animal nutrition and wellness, automation, automotive, chemicals & materials, consumer goods & services, electronics, energy & power, financial services, food & beverages, healthcare, hospitality & tourism, information & communications technology, investment opportunities, and logistics. 

For any inquiries, please contact:
[email protected]  
https://www.mordorintelligence.com/contact-us

Logo: https://mma.prnewswire.com/media/2746908/Mordor_Intelligence_Logo.jpg

View original content:https://www.prnewswire.com/news-releases/exosomes-market-led-by-north-america-with-53-revenue-share-and-global-market-size-set-to-surpass-usd-2b-by-2030-says-mordor-intelligence-302635159.html